The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq. Myrbetriq (mirabegron), the first drug in its class, works …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

